Covered recipient · General Payments record
KIMYETTA M ROBINSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$610.15
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $347.40 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $149.07 | 1 |
| Astellas Pharma US Inc | $42.87 | 2 |
| Lilly USA, LLC | $36.72 | 2 |
| Merck Sharp & Dohme Corporation | $31.88 | 2 |
| Hologic Sales and Service, LLC | $21.86 | 1 |
| PFIZER INC. | $17.89 | 1 |
| GlaxoSmithKline, LLC. | $17.00 | 1 |
| Novo Nordisk AS | $15.36 | 1 |
| Acerta Pharma LLC | $14.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $149.07 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105960040 | CMS |
| Astellas Pharma US Inc | $21.71 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139352985 | CMS |
| Astellas Pharma US Inc | $21.16 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139390032 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.75 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104668065 | CMS |
| GlaxoSmithKline, LLC. | $17.00 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115804478 | CMS |
| Hologic Sales and Service, LLC | $21.86 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084905890 | CMS |
| Lilly USA, LLC | $18.86 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135116051 | CMS |
| Lilly USA, LLC | $17.86 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135133550 | CMS |
| Merck Sharp & Dohme LLC | $17.00 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141767763 | CMS |
| Merck Sharp & Dohme LLC | $14.88 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141892764 | CMS |
| Novo Nordisk Inc | $15.36 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097433817 | CMS |
| PFIZER INC. | $17.89 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131498069 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.